Utama › Kanser Oral
Kajian klinikal Kanser Oral sedang mengambil peserta di AS
44 kajian untuk Kanser Oral sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Atlanta, GA9 kajian
- New York City, NY8 kajian
- Chicago, IL8 kajian
- St. Louis, MO8 kajian
- Durham, NC7 kajian
- Pittsburgh, PA7 kajian
- Milwaukee, WI7 kajian
- Kansas City, MO7 kajian
- Ann Arbor, MI7 kajian
- Houston, TX7 kajian
- Richmond, VA7 kajian
- Edison, NJ6 kajian
- Philadelphia, PA6 kajian
- Nashville, TN6 kajian
- Kansas City, KS6 kajian
- Omaha, NE6 kajian
- Oklahoma City, OK6 kajian
- Portland, OR6 kajian
- Queens, NY5 kajian
- Decatur, IL5 kajian
- Mountain View, CA5 kajian
- Naperville, IL5 kajian
- Erie, PA5 kajian
- Detroit, MI5 kajian
- Champaign, IL5 kajian
- Charleston, IL5 kajian
- Los Angeles, CA5 kajian
- Danville, IL5 kajian
- Overland Park, KS5 kajian
- Phoenix, AZ5 kajian
- Stevens Point, WI5 kajian
- Joliet, IL5 kajian
- Peoria, IL5 kajian
- Bloomington, IL5 kajian
- Wausau, WI5 kajian
- Cedar Rapids, IA5 kajian
- Cape Girardeau, MO5 kajian
- Baltimore, MD5 kajian
- Cincinnati, OH5 kajian
- Toledo, OH4 kajian
Mengikut negeri
- Arizona7 kajian
- Arkansas5 kajian
- California13 kajian
- Colorado8 kajian
- Connecticut3 kajian
- Florida11 kajian
- Georgia9 kajian
- Idaho3 kajian
- Illinois10 kajian
- Indiana5 kajian
- Iowa8 kajian
- Kansas9 kajian
- Kentucky5 kajian
- Louisiana3 kajian
- Maryland6 kajian
- Massachusetts5 kajian
- Michigan9 kajian
- Minnesota8 kajian
- Missouri10 kajian
- Montana4 kajian
- Nebraska6 kajian
- New Hampshire4 kajian
- New Jersey8 kajian
- New Mexico3 kajian
- New York13 kajian
- North Carolina9 kajian
- North Dakota4 kajian
- Ohio14 kajian
- Oklahoma6 kajian
- Oregon6 kajian
- Pennsylvania10 kajian
- South Carolina5 kajian
- South Dakota4 kajian
- Tennessee8 kajian
- Texas9 kajian
- Vermont3 kajian
- Virginia7 kajian
- Wisconsin9 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07195734DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05136196Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06980038Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05172245Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06736379Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07343596Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07156227Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT07441681Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07110142Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06627270Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06819228Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT07121595Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT06448026Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT01269190Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT04198766Role of Acetaldehyde in the Development of Oral Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 45 · Semua jantina · Dikemas kini 22 Jul 2026 · NCT05973656Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06662058Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07460765Integrated Cancer Repository for Cancer Research
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.